Startups
Myricx Pharma

Drug discovery platform focused on developing small molecule inhibitors.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Seedtable Score

Score icon 44

Locations

Company Size

  • 1 - 11

Last Stage Round

Industry

Insights

Myricx Pharma, based in London, operates a drug discovery platform specializing in small molecule inhibitors for specific diseases. By focusing on targeted treatments, Myricx has carved a niche in the pharmaceutical landscape. This B2B model allows for collaboration with major pharma firms, potentially increasing market reach and innovation. With investment backing from Sofinnova Partners, the company is financially well-positioned. However, their focus on small molecule inhibitors may slow drug development and risk missing novel treatment opportunities. Despite this, Myricx's expertise distinguishes it from competitors using conventional drug discovery methods.

Total Funding
$6.0M
Investors